Trial
NCT04184323
SIRT-1 Antagonism for Endometrial Receptivity
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Endometriosis
Intervention
EX-527 (Selisistat)
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-11-17